BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

CUSIP: 09058V103

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
210,587,372
Total 13F shares
133,168,915
Share change
+10,561,446
Total reported value
$634,861,180
Put/Call ratio
33%
Price per share
$4.76
Number of holders
160
Value change
+$96,615,986
Number of buys
104
Number of sells
56

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
6.4%
13,395,617
$26,790,000 31 Mar 2020
13F
BAKER BROS. ADVISORS LP
13F
Company
5.2%
10,946,166
$21,892,000 31 Mar 2020
13F
VANGUARD GROUP INC
13F
Company
4.2%
8,772,116
$17,544,000 31 Mar 2020
13F
Eversept Partners, LP
13F
Company
3.6%
7,542,372
$15,084,744 31 Mar 2020
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
3.6%
7,500,000
$15,000,000 31 Mar 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
3.1%
6,452,341
$12,905,000 31 Mar 2020
13F
CITADEL ADVISORS LLC
13F
Company
2.9%
6,109,534
$12,219,000 31 Mar 2020
13F
STATE STREET CORP
13F
Company
2.7%
5,746,052
$11,492,000 31 Mar 2020
13F
UBS Group AG
13F
Company
2.4%
5,083,238
$10,166,000 31 Mar 2020
13F
JANUS HENDERSON GROUP PLC
13F
Company
2.3%
4,877,731
$9,755,000 31 Mar 2020
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
2.2%
4,652,926
$9,306,000 31 Mar 2020
13F
Point72 Asset Management, L.P.
13F
Company
1.4%
3,018,132
$6,036,000 31 Mar 2020
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
1.4%
3,005,676
$6,011,000 31 Mar 2020
13F
FMR LLC
13F
Company
1.2%
2,556,584
$5,113,000 31 Mar 2020
13F
DEUTSCHE BANK AG\
13F
Company
1.1%
2,320,459
$4,641,000 31 Mar 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1%
2,203,678
$4,406,000 31 Mar 2020
13F
STIFEL FINANCIAL CORP
13F
Company
0.99%
2,090,969
$4,182,000 31 Mar 2020
13F
Ghost Tree Capital, LLC
13F
Company
0.95%
2,000,000
$4,000,000 31 Mar 2020
13F
NORTHERN TRUST CORP
13F
Company
0.89%
1,869,130
$3,738,000 31 Mar 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.85%
1,781,249
$3,562,000 31 Mar 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.76%
1,599,912
$3,200,000 31 Mar 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.7%
1,464,540
$2,929,000 31 Mar 2020
13F
Woodline Partners LP
13F
Company
0.6%
1,254,527
$2,509,000 31 Mar 2020
13F
BARCLAYS PLC
13F
Company
0.55%
1,148,846
$2,298,000 31 Mar 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.54%
1,131,521
$2,263,000 31 Mar 2020
13F
Parkman Healthcare Partners LLC
13F
Company
0.47%
995,608
$1,991,000 31 Mar 2020
13F
CREDIT SUISSE AG/
13F
Company
0.42%
874,391
$1,749,000 31 Mar 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.41%
859,007
$1,719,000 31 Mar 2020
13F
Sofinnova Investments, Inc.
13F
Company
0.39%
815,690
$1,632,000 31 Mar 2020
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.37%
771,386
$1,543,000 31 Mar 2020
13F
MORGAN STANLEY
13F
Company
0.33%
691,848
$1,383,000 31 Mar 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.31%
661,546
$1,324,000 31 Mar 2020
13F
Bank of New York Mellon Corp
13F
Company
0.31%
650,638
$1,301,000 31 Mar 2020
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.29%
611,934
$1,224,000 31 Mar 2020
13F
DAFNA Capital Management LLC
13F
Company
0.23%
479,051
$958,000 31 Mar 2020
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.19%
390,367
$781,000 31 Mar 2020
13F
Spark Investment Management LLC
13F
Company
0.18%
372,700
$745,000 31 Mar 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.16%
331,655
$663,000 31 Mar 2020
13F
Swiss National Bank
13F
Company
0.14%
298,800
$598,000 31 Mar 2020
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.12%
250,000
$500,000 31 Mar 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.11%
241,320
$483,000 31 Mar 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.11%
228,854
$458,000 31 Mar 2020
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.11%
228,600
$457,000 31 Mar 2020
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.09%
191,764
$383,000 31 Mar 2020
13F
HSBC HOLDINGS PLC
13F
Company
0.09%
193,165
$382,000 31 Mar 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.09%
188,708
$377,000 31 Mar 2020
13F
Russell Investments Group, Ltd.
13F
Company
0.08%
161,807
$323,000 31 Mar 2020
13F
Walleye Capital LLC
13F
Company
0.07%
156,507
$313,000 31 Mar 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.07%
156,500
$313,000 31 Mar 2020
13F
CITIGROUP INC
13F
Company
0.07%
144,469
$288,000 31 Mar 2020
13F

Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q2 2020

As of 30 Jun 2020, BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 133,168,915 shares. The largest 10 holders included STATE STREET CORP, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, Eversept Partners, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), TWO SIGMA INVESTMENTS, LP, and FMR LLC. This page lists 160 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
127
Q2 2020 holders
160
Holder diff
33
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.